Engineered T cell-receptor based therapy of pancreatic ductal adenocarcinoma

被引：0
|
作者：
Stromnes, Ingunn M. [1 ]
Schmitt, Thomas M. [1 ]
Brockenbrough, Scott J. [1 ]
Nguyen, Hieu [1 ]
Cuevas, Carlos [2 ]
Hulbert, Ayaka [1 ]
Hotes, Jennifer [1 ]
Dotson, Ashley [1 ]
Hingorani, Sunil R. [1 ]
Greenberg, Philip D. [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Washington, Seattle, WA 98195 USA
来源：
CANCER IMMUNOLOGY RESEARCH | 2016年 / 4卷 / 01期
关键词：
D O I：
10.1158/2326-6074.CRICIMTEATIAACR15-IA38
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA38
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
    Beatty, Gregory L.
    ONCOIMMUNOLOGY, 2014, 3 (04):
  • [2] The T cell architecture of pancreatic ductal adenocarcinoma
    Sivakumar, S.
    Abu-Shah, E.
    Ahern, D.
    Mangal, N.
    Reddy, S.
    Rendek, A.
    Silva, M.
    Soonawalla, Z.
    Middleton, M.
    Dustin, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [3] Enhanced affinity T cell receptor based therapy can surmount immune and physical barriers to treat pancreatic ductal adenocarcinoma
    Stromnes, Ingunn M.
    Brockenbrough, Scott J.
    Schmitt, Thomas M.
    Hingorani, Sunil R.
    Greenberg, Philip D.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [4] The T-cell architecture of pancreatic ductal adenocarcinoma
    Sivakumar, Shivan
    Abu Shah, Enas
    Ahern, David
    Mangal, Nagina
    Reddy, Srikanth
    Rendek, Aniko
    Soonawalla, Zahir
    Silva, Michael
    Middleton, Mark
    Dustin, Michael
    CANCER RESEARCH, 2019, 79 (24)
  • [5] Pre-existing T cell inflammation is a determinant of response to mesothelin chimeric antigen receptor T cell therapy in pancreatic ductal adenocarcinoma
    Plesset, Jacqueline B.
    Coho, Heather
    Markowitz, Kelly
    Patel, Dhruv
    Wattenberg, Max M.
    Stone, Meredith L.
    Delman, Devora
    Beatty, Gregory L.
    CANCER RESEARCH, 2024, 84 (02)
  • [6] Engineered Bacteria Manipulate Cysteine Metabolism to Boost Ferroptosis-Based Pancreatic Ductal Adenocarcinoma Therapy
    Qiao, Chaoqiang
    Wang, Lexuan
    Huang, Chuting
    Jia, Qian
    Bao, Weier
    Guo, Peilin
    Tan, Dengxu
    Chen, Zhuang
    Shi, Changhong
    Rao, Zhiping
    Zhang, Ruili
    Wei, Wei
    Wang, Zhongliang
    ADVANCED MATERIALS, 2025, 37 (06)
  • [7] T-cell regulation in pancreatic ductal adenocarcinoma.
    Sivakumar, Shivan
    Abu-Shah, Enas
    Ahern, David
    Mangal, Nagina
    Reddy, Srikanth
    Rendek, Aniko
    Soonawalla, Zahir
    Silva, Michael
    Middleton, Mark
    Dustin, Michael L.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 76 - 77
  • [8] EVALUATION OF CD318 AS TARGET FOR CAR T CELL THERAPY OF PANCREATIC DUCTAL ADENOCARCINOMA
    Vanderliek, K.
    Schaefer, D.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A12 - A13
  • [9] Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
    Karimnia, Vida
    Slack, Frank J.
    Celli, Jonathan P.
    CANCERS, 2021, 13 (17)
  • [10] T CELL RECEPTOR EXCHANGE BY ZYGOTE ENGINEERING RESULTS IN PHYSIOLOGICAL T CELL RESPONSES FOR THERAPEUTIC USE IN PANCREATIC DUCTAL ADENOCARCINOMA
    Rollins, Meagan
    Raynor, Jackson
    Miller, Ebony
    Spartz, Ellen
    Lahr, Walker
    Burrack, Adam
    You, Yun
    Morarity, Branden
    Webber, Beau
    Stromnes, Ingunn
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A687 - A687
12345